Pain and Fear of Venous Blood Collection in Children

July 28, 2022 updated by: Türkan Kadiroğlu, Ataturk University

The Effect of Chocolate Smell and Stress Ball on Pain and Fear in Venous Blood Collection in Children

Nurses are in the position of primary health care provider in relieving children's pain and fears of bloodletting in the wards where they work. As a result of this study, it is aimed to encourage nurses to apply non-pharmacological interventions during painful medical procedures, to facilitate the provision of necessary and different means of distraction to blood collection services, and to contribute to the development of in-house health policies and the preparation of appropriate clinical guides and to add an innovative perspective.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

126

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Erzurum, Turkey, 25240
        • Ataturk University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 12 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 6-12 age group,
  • children who need blood drawn for any reason
  • have no disease that can cause chronic pain,
  • no olfactory disorder
  • no mental or neurological problems
  • able to communicate
  • speaks Turkish

Exclusion Criteria:

  • those who did not give consent to the research by both the child and the parent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Experimental: Chocolate Scent
Other: Chocolate Scent

Chocolate Scent:Children in this group will be given chocolate scent sniffing as a non-pharmacological distraction method.

Stress Ball:Stress ball squeezing will be used as a non-pharmacological distraction method for children in this group.

Other Names:
  • Stress Ball
Experimental: Stress Ball
Other: Chocolate Scent

Chocolate Scent:Children in this group will be given chocolate scent sniffing as a non-pharmacological distraction method.

Stress Ball:Stress ball squeezing will be used as a non-pharmacological distraction method for children in this group.

Other Names:
  • Stress Ball

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Wong-Baker Faces Pain Rating Scale
Time Frame: 12 week
12 week
Child Fear Scale
Time Frame: 12 week
12 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ataturk University

Collaborators

MSc Eylem Nazan KAPAN

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2022

Primary Completion (Actual)

May 30, 2022

Study Completion (Actual)

June 30, 2022

Study Registration Dates

First Submitted

March 19, 2022

First Submitted That Met QC Criteria

March 19, 2022

First Posted (Actual)

March 29, 2022

Study Record Updates

Last Update Posted (Actual)

July 29, 2022

Last Update Submitted That Met QC Criteria

July 28, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • B.30.2.ATA.O.O.0l 0/184

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe